Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole
Clinical Infectious Diseases2007Vol. 45(1), pp. 76–80
Citations Over TimeTop 1% of 2007 papers
Tihana Bicanic, Graeme Meintjes, Robin Wood, Meg Hayes, Kevin Rebe, Linda‐Gail Bekker, Thomas S. Harrison
Abstract
In a prospective observational study of 54 patients with human immunodeficiency virus-associated cryptococcal meningitis, the early fungicidal activity of amphotericin B (1 mg/kg/day) was significantly greater than that of fluconazole (400 mg/day). Compared with antiretroviral therapy-naive patients, patients developing cryptococcal meningitis while already receiving antiretroviral therapy had lower baseline fungal burdens and a longer median duration of survival, but there were no differences observed in fungal clearance, cerebrospinal fluid proinflammatory cytokines, or 10-week mortality.
Related Papers
- → Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis(2016)27 cited
- → Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil(1992)56 cited
- Cryptococcus neoformans and cryptococcosis.(1970)
- → A retrospective study on the frequency of cryptococcosis in University Malaya Medical Centre from year 2013 to September 2019(2020)